Literature DB >> 3490780

HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors.

M I Anastasiou-Nana, J L Anderson, J F Carlquist, J N Nanas.   

Abstract

Several autoimmune diseases have been associated with increased frequencies of specific histocompatibility (HLA) antigens, particularly for the D (DR) locus, that may be linked to immune response genes. Rheumatic valvular heart disease (RHD) has been postulated to have autoimmune features, but HLA associations have not been established. We, therefore, performed HLA-DR typing in 33 consecutive patients with RHD and in 82 normal blood bank control subjects. We also evaluated the frequencies of lymphocyte subsets by means of monoclonal antibodies and immunofluorescence flow cytometry and made functional correlations for the natural killer cell (NKC) in patient subsets. The DR patterns in RHD were heterogeneous. However, significant differences were noted for DR4 and DR6. DR4 was present in 52% (17 of 33) of RHD patients vs 32% (26 of 82) of control subjects (p less than 0.05). DR6 was present in 6% (2 of 33) of patients vs 26% (21 of 82) of control subjects (p less than 0.02). The associated relative odds of DR4 was 2.3 and the etiologic fraction was 0.30. The relative odds of DR6 was 0.19 and the preventive fraction was 0.21. A distinct clinical profile was not associated with DR4 positivity or DR6 negativity. The frequency of lymphocyte subsets was not significantly changed except for OKT8. Median NKC numbers tended to be higher in RHD patients than in control subjects (p less than 0.05). In contrast, NKC functional activity tended to be lower in RHD; median lymphocyte to target cell (K562 line) ratio resulting in 50% killing (L/T 50) was 20.5 in RHD patients vs 11.5 in control subjects (p = 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490780     DOI: 10.1016/0002-8703(86)90311-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

1.  T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients.

Authors:  L Guilherme; S E Oshiro; K C Faé; E Cunha-Neto; G Renesto; A C Goldberg; A C Tanaka; P M Pomerantzeff; M H Kiss; C Silva; F Guzman; M E Patarroyo; S Southwood; A Sette; J Kalil
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 2.  Immunogenetic basis of myocarditis: role of fibrillary antigens.

Authors:  K W Beisel
Journal:  Springer Semin Immunopathol       Date:  1989

3.  Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody.

Authors:  A K Khanna; D R Buskirk; R C Williams; A Gibofsky; M K Crow; A Menon; M Fotino; H M Reid; T Poon-King; P Rubinstein
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

Review 4.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

Review 5.  Cutting edge issues in rheumatic fever.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

6.  Various rheumatic syndromes in adult patients associated with high antistreptolysin O titres and their differential diagnosis with rheumatic fever.

Authors:  J M Valtonen; S Koskimies; A Miettinen; V V Valtonen
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

7.  HLA and rheumatic fever in Turkish Children.

Authors:  H E Khosroshahi; O Kahramanyol; L Doğanci
Journal:  Pediatr Cardiol       Date:  1992-10       Impact factor: 1.655

8.  Role of antigen-presenting cells in activation of human T cells by the streptococcal M protein superantigen: requirement for secreted and membrane-associated costimulatory factors.

Authors:  G Majumdar; H Ohnishi; M A Tomai; A M Geller; B Wang; M E Dockter; M Kotb
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

9.  Rheumatic Fever.

Authors:  Ma Binotto; L Guilherme; Ac Tanaka
Journal:  Images Paediatr Cardiol       Date:  2002-04

10.  HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children.

Authors:  Valda Stanevicha; Jelena Eglite; Dace Zavadska; Arturs Sochnevs; Ruta Shantere; Dace Gardovska
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.